Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trials

0 25

AstraZeneca PLC and Eli Lilly & Co. on Tuesday scrapped two late-stage trials of an experimental Alzheimer’s drug they had been co-developing, the newest blow within the lengthy quest to discover a breakthrough for the memory-robbing dysfunction.

The businesses mentioned the choice was taken after an impartial information monitoring committee concluded that trials related to lanabecestat, the experimental drug, wouldn’t obtain their authentic objectives. The businesses mentioned the remedy wasn’t working in addition to that they had hoped and ending the trials…

Supply hyperlink – https://www.wsj.com/articles/eli-lilly-astrazeneca-drop-two-late-stage-alzheimers-drug-trials-1528797681?mod=pls_whats_news_us_business_f

You might also like

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.